4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Weight Gain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futenma, A; Iwata, K; Kusunoki, M; Miyata, T; Mizutani, K; Nakamura, T; Nomura, T; Ogawa, H; Tsutsumi, K; Utsumi, K; Yin, W | 1 |
| Cameron-Smith, D; Cooney, GJ; Hara, T; Kusunoki, M; Storlien, LH; Tsutsumi, K | 1 |
2 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Weight Gain
| Article | Year |
|---|---|
NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Benzamides; Blood Glucose; Carrier Proteins; Dietary Fats; Eating; Gene Expression Regulation; Insulin; Ion Channels; Lipoprotein Lipase; Male; Mitochondrial Proteins; Muscle, Skeletal; Obesity; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uncoupling Protein 3; Weight Gain | 2005 |
The actions of a novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructose-fed rats.
Topics: Animals; Benzamides; Enzyme Activation; Fructose; Glucose; Hypertriglyceridemia; Lipoprotein Lipase; Male; Organophosphorus Compounds; Pulmonary Gas Exchange; Rats; Rats, Sprague-Dawley; Triglycerides; Weight Gain | 1998 |